Ikarian Capital »

Definium Therape shares owned by Ikarian Capital

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 59k 18.90

More positions owned by Ikarian Capital

Terns Pharmaceuticals (TERN)
Spdr Series Trust State Street Spd Put Option (XBI)
Cytokinetics Com New (CYTK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Kodiak Sciences (KOD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Abivax Sa Sponsored Ads (ABVX)
Alumis (ALMS)
Bristol Myers Squibb Put Option (BMY)
Capricor Therapeutics Com New (CAPR)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Praxis Precision Medicines I Com New (PRAX)
Biosante Pharmaceuticals (ANIP)
Harrow Health (HROW)

View all positions for Ikarian Capital

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape